Finjan, Inc. v. ESET, LLC et al
Filing
699
ORDER on Motions for Summary Judgment and Motions to Exclude or Strike. [Doc. Nos. 466 , 467 , 469 , 470 , 474 , 476 , 478 , 479 , 481 , 483 , 484 , 486 , 488 , 490 , 492 , 494 , 497 , 499 , 501 , 506 , 509 , 510 , 513 , 515 , 524 , 526 , 530 , 531 ]. Signed by Judge Cathy Ann Bencivengo on 10/16/2019. (anh)
1
2
3
4
5
6
7
8
UNITED STATES DISTRICT COURT
9
SOUTHERN DISTRICT OF CALIFORNIA
10
11
FINJAN, INC.,
Case No.: 17-CV-183-CAB-BGS
Plaintiff,
12
13
v.
14
ORDER ON MOTIONS FOR
SUMMARY JUDGMENT AND
MOTIONS TO EXCLUDE OR
STRIKE
[Doc. Nos. 466, 467,469, 470, 474, 476,
ESET, LLC et al.,
Defendants.
15
16
17
478, 479, 481, 483, 484, 486, 488, 490,
492, 494, 497, 499, 501, 506, 509, 510,
AND RELATED COUNTERCLAIMS
18
513, 515, 524, 526, 530, 531]
19
20
I.
21
At the close of fact and expert discovery and in accordance with the scheduling order
22
in this case, the parties filed motions for summary judgment, Daubert motions challenging
23
each other’s experts, and motions to exclude certain evidence. The Court provided no
24
limitations regarding the number of dispositive motions that could be filed or total page
25
limitations. The parties took extreme advantage of this and filed in total twenty-eight
26
complex motions, putting before the Court an extraordinary number of issues purportedly
27
without material facts in dispute and therefore proper for adjudication as a matter of law.
28
Having reviewed the voluminous briefing, declarations and exhibits submitted by both
Introduction
1
17-CV-183-CAB-BGS
1
parties, the Court concludes that for the majority of the substantive motions, facts were
2
most definitely in dispute and summary judgment was not appropriate. Similarly, for the
3
majority of the challenges to the admissibility of expert testimony, the Court concludes that
4
the challenges go to the weight to be afforded the opinions. They are best challenged by
5
cross-examination rather than deemed inadmissible and excluded as an exercise of the
6
Court’s gatekeeper role.
7
A number of the motions to exclude certain evidence centered on accusations of
8
untimely disclosures and resulting prejudice to the moving party. These accusations flew
9
in both directions, and the pages of briefing allocated to these arguments of attorney
10
misconduct were exhausting. Generally, the Court concludes that there was no undue
11
prejudice and that all of the evidence in question can be presented to a jury.
12
Of the twenty-eight motions, the Court held a hearing on six motions on September
13
26, 2019. [Doc. No. 679, transcript of 9/26/19 hrg.] Those six motions are addressed
14
below. As to the remaining twenty-two motions, the Court issued tentative rulings [Doc.
15
No. 695] which remain unchanged.
16
17
18
19
ESET’s Motions
II.
A.
Summary Judgment of Non-Infringement, License or Unenforceability
The Court finds numerous material facts in dispute as to the following motions and
they are therefore DENIED.
20
• Doc. No. 470 Motion for Non-Infringement of CMPS
21
• Doc. No. 476 Motion for Non-Infringement of ‘621/’755 Patents
22
• Doc. No. 481 Motion for Non-Infringement of ‘844 Patent
23
• Doc. No. 484 Motion for Non-Infringement of ‘086 Patent
24
• Doc. No. 488 Motion for Non-Infringement of ‘780 Patent
25
• Doc. No. 486 Motion for License Defense
26
• Doc. No. 531 Motion for Unenforceability of ‘086, ‘621 and ‘755 Patents
27
28
2
17-CV-183-CAB-BGS
1
B.
Motions to Exclude Experts and Strike Contentions
2
The Court declines to exclude the experts contested in the motions listed below
3
because their opinions are best challenged by cross-examination rather than exclusion. The
4
motions are therefore DENIED. ESET’s request to strike Finjan’s Third Amended
5
Infringement Contentions is also DENIED.
6
• Doc. No. 474 Exclusion of Bims
7
• Doc. No. 479 Exclusion of Mitzenmacher, Medvidovic, Goodrich and Cole
8
• Doc. No. 469 Exclusion of Orso1
9
• Doc. No. 492 Motion to Strike Third Amended Contentions
10
III.
11
A.
12
13
FINJAN’s Motions
Summary Judgment of Infringement or of ESET’s Defenses
The Court finds numerous material facts in dispute as to the following motions and
they are therefore DENIED.
14
• Doc. No. 497 Motion for Infringement of ‘086 Patent
15
• Doc. No. 499 Motion for Infringement of ‘621 Patent
16
• Doc. No. 501 Motion for Infringement of ‘780 Patent
17
• Doc. No. 506 Motion for No License Defense
18
• Doc. No. 509 Motion for No Inequitable Conduct
19
• Doc. No. 513 Motion for Validity over Certain Prior Art References
20
B.
21
22
Motions to Exclude Experts and Strike Evidence
The Court declines to exclude the experts contested in the motions listed below
because their opinions are best challenged by cross-examination rather than exclusion. The
23
24
25
26
1
27
28
ESET moved to exclude the testimony of Dr. Alexxandro Orso regarding his opinions as to secondary
considerations of non-obviousness. The Court RESERVES on this motion. ESET may voir dire this
witness out of the presence of the jury to determine if his opinions are supported by the requisite nexus
between the inventions and his conclusions regarding the secondary considerations of non-obviousness.
3
17-CV-183-CAB-BGS
1
motions are therefore DENIED. Finjan’s motions to exclude certain prior art and non-
2
infringing alternatives are also DENIED.
3
• Doc. No. 510 Exclusion of Thompson
4
• Doc. No. 515 Exclusion of Spafford
5
• Doc No. 524 Exclusion of Britven
6
• Doc. No. 530 Motion to Exclude Certain Prior Art
7
• Doc. No. 526 Motion to Exclude Non-Infringing Alternatives.
8
9
IV.
A.
The Remaining Motions
Priority Dates [Doc. No. 483]
10
As stated on the record at the hearing, this motion is DENIED as to ESET’s
11
proposed priority dates for the ‘780, ‘086, ‘621 and ‘755 patents. There are material facts
12
in dispute regarding whether the earlier patents to which Finjan claims priority disclose the
13
inventions claimed in these patents.
14
The Court, however, was prepared to adopt the IPR decision that the inventors of the
15
‘844 patent were not in possession of the subject matter of the challenged claims of that
16
patent any time prior to the December 22, 1997 filing date of the 08/995,648 application.
17
[Doc. No. 483-20, at 21-25; Doc. No. 697, at 51.] The parties represented that there had
18
been further developments in the Patent Office regarding that determination. The matter
19
therefore remains under submission pending updates from the parties.
20
B.
ESET Motion re: Indefiniteness of “Downloadable” [Doc. No. 478]
21
The genesis of this motion goes back to the claim construction of the term
22
“Downloadable.” The Court references the claim construction order [Doc. No. 195], the
23
portion of the claim construction hearing regarding this term [Doc. No. 610-3], and the
24
portion of the hearing on this motion [Doc. No. 697 at 3:13-22:19] for context. In
25
summary, the term “Downloadable” is defined by the inventor somewhat differently in the
26
lineage of the patents at issue. In U.S. Patent No. 6,167,520, filed January 29, 1997, it is
27
defined as, “a small executable or interpretable application program which is downloaded
28
from a source computer.” In U.S. Patent No. 6,092,194, filed November 6, 1997 and
4
17-CV-183-CAB-BGS
1
incorporating the ‘520 patent, it is defined as “an executable application program which is
2
downloaded from a source computer.” Both specifications use the sample examples of
3
executable and interpretable application programs to identify what constitutes a
4
“Downloadable.” Because both definitions are incorporated by reference throughout the
5
patents, and the Court found they could be reconciled, the Court adopted the definition set
6
for in U.S. Patent 6,167,520, that patent being incorporated into all the subsequent patents
7
in the family tree.
8
The definition of “Downloadable” in the ‘520 patent includes “small” as a
9
description of the executable programs that are defined as a “Downloadable.” At the time
10
of claim construction the Court noted that this term of size might lead to an indefiniteness
11
issue if persons of skill in the art on January 29, 1997, the date the ‘520 patent was filed,
12
did not understand what would constitute “small” with respect to “executable programs
13
from a source computer that run on the destination computer.” That question, however,
14
was left for another day.2
15
That day has come and ESET now contends that “Downloadable” is an indefinite
16
term and as it is a claim limitation in all asserted claims of the five asserted patents, each
17
is invalid under 35 U.S.C. § 112, which requires “that a patent’s claims, viewed in light of
18
the specification and prosecution history, inform those skilled in the art about the scope of
19
the invention with reasonable certainty.” Nautilus, Inc. v. Biosig Instruments, Inc., 572
20
U.S. 898, 910 (2014). While there need not be precise numerical certainty, there must be
21
no more than a “modicum of uncertainty.” Id.
22
ESET has the burden of proving indefiniteness by clear and convincing evidence.
23
Biosig Instruments, Inc. v. Nautilus, Inc., 783 F.3d 1374, 1377 (Fed. Cir. 2015). ESET
24
presented evidence in its motion that Finjan’s experts had difficulty setting forth a
25
26
27
28
Finjan’s objection that the defense of indefiniteness is untimely and should be struck is denied. This
issue was identified at claim construction and Finjan was on notice that ESET would likely pursue it.
2
5
17-CV-183-CAB-BGS
1
consistent understanding of how a person of skill in the art in 1997 would interpret a “small
2
executable program.” Finjan countered that the kinds of programs identified as examples
3
in the patent disclosure would provide adequate notice to a person of skill what was
4
encompassed by the term “small.” Based on conflicting record before the Court, the Court
5
cannot find at this time that ESET has demonstrated by clear and convincing evidence that
6
the definition of “Downloadable” is indefinite. The motion for summary judgment is
7
therefore DENIED without prejudice to ESET demonstrating this invalidity defense at
8
trial.
9
C.
Exclusion of Dr. Ricardo Valerdi Testimony [Doc. No. 490]
10
ESET moves to exclude the testimony of Dr. Ricardo Valerdi. Federal Rule of
11
Evidence 702 creates “a gatekeeping role for the judge” to “ensure that an expert’s
12
testimony both rests on a reliable foundation and is relevant to the task at hand.” Daubert
13
v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 597 (1993). Dr. Valerdi offers an
14
opinion employing a computer model to ascertain the cost he estimates that ESET incurred
15
to develop and maintain the accused software incorporated into the accused products.
16
Finjan however acknowledges that it has “verified ESET’s costs by analyzing (i) financial
17
statements produced by ESET to estimate the maintenance and ongoing development costs
18
ESET actually incurred related to the infringing systems; and (ii) the testimony of ESET’s
19
head of finance, Ms. Jana Michalakova, regarding ESET’s actual development and costs
20
related to the accused technologies for the relevant time period.” [Doc. No. 602 at 20.]
21
Rather than rely on estimates derived from actual financial data, Finjan employed Dr.
22
Valerdi to model the costs to develop and maintain the accused systems.
23
This model is offered as evidence to support a cost savings analysis. Dr. Valerdi’s
24
modeling however estimates the cost of developing the existing ESET software, not
25
alternative non-infringing software. It therefore has no relevance to a cost savings analysis.
26
“Reliance upon estimated cost savings from use of the infringing product is a well settled
27
method of determining a reasonable royalty.” Hanson v. Alpine Valley Ski Area, Inc., 718
28
F.2d 1075, 1080-81 (Fed. Cir. 1983). The comparison, however, should be to the costs of
6
17-CV-183-CAB-BGS
1
developing a non-infringing alternative. Prism Techs. LLC v. Sprint Spectrum L.P., 849
2
F.3d 1360, 1376 (Fed. Cir. 2017) (costs saved by renting an infringing structure versus
3
building a non-infringing structure). Dr. Valerdi’s modeling exercise is based not on
4
creating a non-infringing alternative system, but on recreating the accused system.
5
The Court finds no value in substituting the estimated actual costs of developing and
6
maintaining ESET’s alleging infringing system with Dr. Valerdi’s model. Such modeling
7
may be of assistance when actual costs cannot be determined, but that is not the situation
8
here. Because the actual costs can be determined, Dr. Valerdi’s hypothetical construction
9
of ESET’s costs is facially unreasonable. Such proposed testimony on the creation of
10
unverifiable estimates from disputed inputs to come to a facially unreasonable hypothetical
11
number as to the costs of developing and maintaining the accused technologies will be
12
confusing and misleading to the jury, prejudicial to the defendant, and a waste of time. The
13
motion to exclude the testimony of Dr. Valerdi is GRANTED pursuant to Federal Rule of
14
Evidence 403.
15
D.
Exclusion of Dr. Eric Cole Testimony [Doc. No. 494]
16
ESET moves to exclude the testimony of Dr. Eric Cole. Dr. Cole provides opinions
17
on the infringement of the ‘844 patent, the cost to ESET of implementing a non-infringing
18
alternative to all the patents-at-issue, inputs for Dr. Valerdi’s cost estimation model, and
19
willfulness.
20
The motion to exclude as to Dr. Cole’s opinion regarding infringement of the ‘844
21
patent is DENIED. ESET challenges many of the assumptions and conclusions of Dr.
22
Cole’s infringement opinion, but the Court concludes that is best left to cross-examination.
23
Regarding Dr. Cole’s other opinions, however, the motion is GRANTED. The
24
Court has excluded Dr. Valerdi’s testimony, therefore the Court strikes as irrelevant and
25
confusing, under Rule 403, any testimony by Dr. Cole regarding the number of lines of
26
code that make up the infringing functionality of the patents-at-issue. This testimony is
27
also excluded in that Dr. Cole was not identified as an expert on the infringement of any
28
7
17-CV-183-CAB-BGS
1
patents except the ‘844 patent. Consequently, his opinions of what source code executes
2
the infringing functionality of the patents not within his purview are excluded.
3
Dr. Cole’s opinion on the costs of ESET providing its services through a “non-
4
infringing alternative,” (i.e., manually processing the files) is also excluded. Finjan
5
acknowledged at the hearing on this motion that this proposed alternative is not viable.
6
[Doc. No. 697, at 81:17-82:12.] Introducing the prohibitive cost and time of performing
7
such processing manually, when it is recognized by all Finjan’s experts as a non-viable
8
alternative, would only serve to mislead and confuse the jury and introduce a prejudicial
9
damages figure into the discussion. It is excluded under Rule 403.3
10
Similarly, Dr. Cole’s opinion regarding willfulness is excluded. Dr. Cole offers an
11
opinion regarding what Finjan calls the standard of care in the industry. Based on Dr.
12
Cole’s personal experience at McAfee, he would opine to the jury that a reasonable
13
company would have reviewed Finjan’s “patented technology” upon learning of Finjan and
14
its enforcement of its patent portfolio. Finjan concedes Dr. Cole does not opine on what
15
ESET did – only what he believes similarly situated reasonable companies would have or
16
should have done. [Doc. No. 589, at 16.]
17
This opinion suggests that there is duty to investigate a competitor’s portfolio rather
18
than a duty to determine if a known patent is infringed. Dr. Cole’s opinion is not whether
19
ESET’s actions when it learned of specific Finjan patents was reasonable. He instead offers
20
an opinion that a prudent company would be actively monitoring a competitor’s patent
21
holdings and failure to do so is below a standard of care. This opinion is likely to mislead
22
and confuse the jury in reaching a determination of whether ESET took due care to
23
24
25
26
27
28
3
Finjan cited Prism Tech, 849 F.3d at 1375, for its holding that it was not error to admit cost savings
evidence based on evidence of the cost Sprint would incur to avoid infringement by building a private
network instead of leasing the services from third-party providers. Prism, however, discusses the costs
and availability of this non-infringing alternative and evidence that Sprint could have attempted to build
its own network. Id. at 1376-77. In this case, Finjan’s experts all agreed that the proposed manual
processing system would not be a viable alternative, so introducing the purported exorbitant cost of
implementing such a system is a distraction and misleading.
8
17-CV-183-CAB-BGS
1
determine if it was infringing after it learned of the patents at issue. The opinion is
2
excluded under Rule 403 as well.
3
E.
Exclusion of Kevin Arst’s Testimony [Doc. No. 467]
4
ESET moves to exclude the testimony of Kevin Arst, who is Finjan’s designated
5
expert on a reasonable royalty. Despite the fact that Finjan has a history of licensing the
6
patents at issue in this case, Mr. Arst apparently elected to ignore established royalty rates,
7
or comparable licenses as benchmarks for his analysis.
8
The reasonable royalty may be based upon an established royalty, if there is one, or
9
if not upon a hypothetical royalty resulting from arm’s length negotiations between a
10
willing licensor and a willing licensee. “Where an established royalty rate for the patented
11
inventions is shown to exist, the rate will usually be adopted as the best measure of
12
reasonable and entire compensation.” Hanson, 718 F.2d at 1078.
13
Mr. Arst’s opinion is based instead on a cost savings analysis – the amount ESET
14
would reasonably pay in lieu of the cost it would incur to manually process files.4 [Doc.
15
No. 599, at 16 (Mr. Arst’s cost-savings opinions are based on Dr. Cole’s assessment that
16
ESET would need to incur the full manual processing costs absent its infringement of the
17
patents-in-suit.).] Although cost savings is a “well settled method of determining a
18
reasonable royalty,” Hanson, 718 F.2d at 1080-81, the Court GRANTS the motion to
19
exclude Mr. Arst’s cost savings opinion because the opinion is based on the unreliable
20
assumption that manual processing is a viable alternative, when, as discussed supra with
21
respect to Dr. Cole’s opinion, it is not.
22
Finjan may revise Mr. Arst’s damages opinion, removing reliance on the opinions
23
of Dr. Valerdi and Dr. Cole. He may not however introduce new materials. ESET will be
24
25
26
27
28
Mr. Arst’s opinion also relies upon Dr. Valerdi’s analysis of the cost of developing and maintaining
ESET’s existing system, as support for the cost “to build a new system.” Dr. Valerdi did not however
estimate the cost of building a non-infringing alternative system and therefore provides no factual
assumption to support Mr. Arst’s royalty analysis. The motion to strike Mr. Arst’s opinion relying on
Dr. Valerdi’s modeling estimates is GRANTED.
4
9
17-CV-183-CAB-BGS
1
given an opportunity to provide a responsive opinion and depose Mr. Arst on any revised
2
opinion. [See Doc. No. 697, at 90:8-16.]
3
4
F.
Summary Judgment of No Willful Infringement and No Pre-Suit
Damages [Doc. No. 466]
5
ESET moves for summary judgment on Finjan’s allegation of willful infringement
6
and to exclude any claim for damages prior to the filing of the complaint. Knowledge of
7
the patent alleged to be willfully infringed is a prerequisite to enhanced damages. Halo
8
Elecs., Inc. v. Pulse Elecs., Inc., 136 S. Ct. 1923, 1932-22 (2016). But knowledge of the
9
patent itself is not enough. Finjan is required to show that ESET “acted despite a risk of
10
infringement that was ‘either known or so obvious that it should have been known’” to
11
ESET. WesternGeco LLC v. ION Geophysical Corp. 837 F.3d 1358, 1362 (Fed. Cir. 2016).
12
Willful infringement is measured by the totality of the circumstances. Finjan claims
13
that Eset should have known of Finjan’s patents, but Finjan presents no evidence that ESET
14
was actually aware of any asserted Finjan patent prior to the receipt of a January 22, 2015
15
letter from Finjan. [Doc. No. 466-4.] In that letter Finjan identifies two of the patents in
16
suit, the ‘844 and ‘086 as relevant to ESET products or services, identifying specific
17
products that correspond to those identified patents. Although no claim charts were
18
provided in January 2015, at that time ESET was on notice of those two patents. No
19
reference was made to, and therefore no notice was given as to the ‘780 patent. The ‘621
20
patent and the ‘755 patent did not even issue until November 17, 2015, and December 22,
21
2015, respectively, so it was an impossibility for the January 22, 2015 letter to constitute
22
notice of infringement of those later issued patents.
23
Following the January 22, 2015 letter, the parties entered into a Standstill Agreement
24
to investigate whether there was infringement and to discuss potential licensing. [Doc. No.
25
466-6.] That Agreement was continued until June 30, 2016. On July 1, 2016 this lawsuit
26
was filed. During the term of the Standstill Agreement the parties agreed to disclose
27
confidential information to assist in the discussion but that the disclosure of such
28
information could not be used to establish a claim for damages or willful infringement.
10
17-CV-183-CAB-BGS
1
Finjan asserts that based on publicly available information, ESET knew throughout
2
the pendency of Standstill Agreement that it was infringing the Finjan patents at issue and
3
that it was negotiating in bad faith. The Court DENIES the motion for summary judgment
4
of willful infringement but cautions Finjan that it must produce evidence at trial that ESET
5
had knowledge of each of the asserted patents and committed subjective willful
6
infringement as of the dates it became aware of those patents. The evidence of ESET’s
7
knowledge cannot be based on disclosures made by Finjan during the Standstill Agreement,
8
but rather must be independent of those discussions.
9
With regard to notice, Finjan has presented no evidence it provided actual notice of
10
infringement to ESET prior to January 22, 2015 for the ‘844 patent and ‘086 patent. Further
11
Finjan has presented no evidence that it provided actual notice of infringement of the ‘780
12
patent, the ‘621 patent and the ‘755 patent outside of disclosures subject to the Standstill
13
Agreement provisions. The Court therefore finds that the damage period starts on January
14
22, 2015 for the ‘844 patent and the ‘086 patent, and on the filing date of the complaint
15
(July 1, 2016) for the ‘780 patent, the ‘621 patent, and the’755 patent.
16
17
It is SO ORDERED.
Dated: October 16, 2019
18
19
20
21
22
23
24
25
26
27
28
11
17-CV-183-CAB-BGS
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?